HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoCalendarPricing
Theme 		Help
Elite 50% OFF Act now – get top investing tools Register Now!
Market News Stocks News ETF News Crypto News

Xenon Pharmaceuticals Inc.

Contributing Author

Recent Articles by Xenon Pharmaceuticals Inc.

Nov-25
Xenon to Present New Azetukalner OLE Study Data in Epilepsy at AES 2025 XENE GlobeNewswire
Nov-06
Xenon to Present at Upcoming Investor Conferences XENE GlobeNewswire
Nov-03
Xenon Reports Third Quarter 2025 Financial Results & Business Update XENE GlobeNewswire
Oct-27
Xenon to Report Q3 2025 Financial Results on November 3, 2025 XENE GlobeNewswire
Oct-16
Xenon Announces Appointment of Tucker Kelly as Chief Financial Officer XENE GlobeNewswire
Oct-07
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) XENE GlobeNewswire
Sep-25
Xenon Announces Upcoming Investor Webinar to Discuss Early-Stage Ion Channel Programs for the Potential Treatment of Pain XENE GlobeNewswire
Aug-29
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) XENE GlobeNewswire
Aug-11
Xenon Reports Second Quarter 2025 Financial Results & Business Update XENE GlobeNewswire
Aug-04
Xenon to Report Q2 2025 Financial Results on August 11, 2025 XENE GlobeNewswire
Aug-01
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) XENE GlobeNewswire
Jun-27
Xenon Joins the Russell 3000 and Russell 2000 Indexes XENE GlobeNewswire
Jun-26
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) XENE GlobeNewswire
Jun-24
Xenon Announces Appointment of Darren Cline as Chief Commercial Officer XENE GlobeNewswire
Jun-03
Xenon to Present at the Goldman Sachs 46th Annual Global Healthcare Conference XENE GlobeNewswire
May-30
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) XENE GlobeNewswire
May-14
Xenon to Present at the 2025 RBC Capital Markets Global Healthcare Conference XENE GlobeNewswire
May-12
Xenon Reports First Quarter 2025 Financial Results and Provides Business Update XENE GlobeNewswire
May-05
Xenon to Report Q1 2025 Financial Results on May 12, 2025 XENE GlobeNewswire
May-02
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) XENE GlobeNewswire
Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.